The country of origin of an IV administration set and an IV extension set
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- Accordingly, the country of origin of the IV Administration Set will be South Korea.
- Accordingly, the country of origin of the IV Extension Set will be South Korea.
Ruling text
In your letter dated April 22, 2025, you requested a country of origin ruling for three medical products on behalf of Codan US Corporation. Additional information was provided by email dated October 22, 2025. One of the products, the transfusion set, will be addressed under a separate correspondence. The IV administration set is composed of a drip chamber, a back check valve, two needle free valves, a roller clam, a slide clamp, a male luer lock and primary PVC tubing (approximately 98”).
It is intended to deliver fluids or medications intravenously from an IV bag to the patient. The set connects to an IV fluid bag via the drip chamber and allows for manual flow control using clamps. The Y-site enables injection of additional medications, and the male luer lock ensures secure connection to the patient's catheter. You assert that the primary functional component is the PVC tubing from South Korea, forming the main fluid path.
It accounts for approximately 74 percent of material cost and 61 percent of total cost. IV Administration set assembly process in China: In a Chinese certified cleanroom, medical grade South Korean primary PVC tubing (2500mm/98.4 inches) is bonded with the Chinese drip chamber, back check valve, luer connector, and Polish or Chinese needle-free valve using cyclohexane solvent. Next, the Chinese roller and slide clamps are added to the tubing.
Lastly, the product is leak tested, packaged and ethylene oxide (EO) sterilized. The IV extension set is designed to extend the reach of primary IV sets and improve patient mobility. It is composed of a female luer lock, a male luer lock, a slide clamp, and PVC tubing (approximately 60”). The set is intended to connect between the primary IV administration set and the patient, allowing for more flexible line management.
You claim that the PVC tubing is the primary component providing the functional channel for fluid transfer. It accounts for approximately 87 percent of material cost and 62 percent of total cost. IV Extension Set assembly process in China: In China, the South Korean PVC tubing is cut to 60 inches and assembled with the Chinese male and female luer connectors using cyclohexanone solvent bonding. A Chinese side clamp is installed; then all components are visually inspected, leak tested, packaged, and EO sterilized.
When determining the country of origin, the substantial transformation analysis is applicable. See, e.g., Headquarters Ruling Letter H301619, dated November 6, 2018. The test for determining whether a substantial transformation will occur is whether an article emerges from a process with a new name, character, or use different from that possessed by the article prior to processing. See Texas Instruments Inc. v. United States, 681 F.2d 778 (C.C.P.A. 1982). This determination is based on the totality of the evidence.
See National Hand Tool Corp. v. United States, 16 C.I.T. 308 (1992), aff’d, 989 F.2d 1201 (Fed. Cir. 1993). For the IV Administration Set, the assembly process in China is considered minor. The bonding and joining of China-origin components to the South Korean PVC tubing do not change the name, character, or use of the pre-cut tubing.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N355059).